• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压的长期镁补充治疗

Long-term magnesium supplementation in essential hypertension.

作者信息

Ferrara L A, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M

机构信息

Institute of Internal Medicine, 2nd Medical School, University of Naples, Italy.

出版信息

Cardiology. 1992;81(1):25-33. doi: 10.1159/000175772.

DOI:10.1159/000175772
PMID:1477853
Abstract

The main objective of this clinical trial was to evaluate the effects of magnesium pidolate (15 mmol/day) on blood pressure at rest and during sympathetic stimulation induced by cold, isometric and tilt test; peripheral blood flow has been evaluated by strain-gauge plethysmography. Fourteen mild to moderate hypertensives (8 males, 6 females, age range 40-60 years) were randomly given magnesium or placebo in a double-blind parallel clinical trial for 6 months. In the actively treated group magnesium urinary excretion increased from 5.3 +/- 2 to 7.7 +/- 2 mmol/24 h, and serum magnesium changed from 0.9 +/- 0.1 to 1.0 +/- 0.2 mmol/l. On magnesium, BP changed at rest from 156/97 +/- 12/4 to 149/90 +/- 8/3 mm Hg, during cold pressor test from 169/105 +/- 9/6 to 174/105 +/- 15/4, during isometric exercise from 170/107 +/- 13/9 to 170/105 +/- 20/6, and during tilt test from 149/96 +/- 11/6 to 153/96 +/- 17/7 mm Hg. Similar changes were observed in the placebo group. Peripheral resistances were 14.7 +/- 4 and 9.8 +/- 2 PRU before and after magnesium, respectively. These data indicate that long-term magnesium pidolate supplementation does not affect blood pressure at rest and during sympathetic stimulation, despite a slight, nonsignificant reduction in forearm peripheral resistance.

摘要

本临床试验的主要目的是评估匹多酸镁(15毫摩尔/天)对静息血压以及冷刺激、等长运动和倾斜试验诱发的交感神经刺激期间血压的影响;采用应变片体积描记法评估外周血流量。在一项双盲平行临床试验中,14名轻度至中度高血压患者(8名男性,6名女性,年龄范围40 - 60岁)被随机给予镁剂或安慰剂,为期6个月。在积极治疗组中,尿镁排泄量从5.3±2增加至7.7±2毫摩尔/24小时,血清镁从0.9±0.1变为1.0±0.2毫摩尔/升。服用镁剂后,静息血压从156/97±12/4毫米汞柱变为149/90±8/3毫米汞柱,冷加压试验期间从169/105±9/6变为174/105±15/4,等长运动期间从170/107±13/9变为170/105±20/6,倾斜试验期间从149/96±11/6变为153/96±17/7毫米汞柱。安慰剂组观察到类似变化。服用镁剂前后外周阻力分别为14.7±4和9.8±2外周阻力单位。这些数据表明,长期补充匹多酸镁不会影响静息血压以及交感神经刺激期间的血压,尽管前臂外周阻力有轻微、无显著意义的降低。

相似文献

1
Long-term magnesium supplementation in essential hypertension.原发性高血压的长期镁补充治疗
Cardiology. 1992;81(1):25-33. doi: 10.1159/000175772.
2
Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure.
Am J Hypertens. 1991 Aug;4(8):674-9. doi: 10.1093/ajh/4.8.674.
3
Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.镁对巴西高血压患者血压及细胞内离子水平的影响。
Int J Cardiol. 1996 Oct 11;56(2):177-83. doi: 10.1016/0167-5273(96)02716-7.
4
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension.口服补充镁对轻至中度高血压女性的降压作用
Am J Clin Nutr. 1994 Jul;60(1):129-35. doi: 10.1093/ajcn/60.1.129.
5
The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study.通过给予镁剂实现的血压剂量依赖性降低。一项双盲安慰剂对照交叉研究。
Am J Hypertens. 1993 Jan;6(1):41-5. doi: 10.1093/ajh/6.1.41.
6
Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet.
Clin Exp Pharmacol Physiol. 1989 Apr;16(4):299-302. doi: 10.1111/j.1440-1681.1989.tb01561.x.
7
Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A double-blind crossover study.
Magnes Res. 1994 Dec;7(3-4):277-83.
8
A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).一项关于咪达普利和坎地沙坦对轻度至中度原发性高血压成年患者降压疗效及耐受性的为期12周的多中心、随机、双盲、平行组、非劣效性试验:伊比利亚多中心咪达普利高血压研究(IMISH)。
Clin Ther. 2006 Dec;28(12):2040-51. doi: 10.1016/j.clinthera.2006.12.006.
9
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.根据基线收缩压评估比索洛尔单药治疗的疗效和耐受性:两项多中心、12 周、随机、双盲、安慰剂对照、平行分组、剂量范围研究的汇总数据的回顾性分析,这些研究纳入了轻至中度原发性高血压患者。
Clin Ther. 2009 Sep;31(9):1946-56. doi: 10.1016/j.clinthera.2009.08.028.
10
Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.补充镁对血压的影响:随机双盲安慰剂对照试验的荟萃分析
Hypertension. 2016 Aug;68(2):324-33. doi: 10.1161/HYPERTENSIONAHA.116.07664. Epub 2016 Jul 11.

引用本文的文献

1
Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.补充镁与血压:随机对照试验的系统评价和荟萃分析
Hypertension. 2025 Nov;82(11):1844-1856. doi: 10.1161/HYPERTENSIONAHA.125.25129. Epub 2025 Sep 26.
2
Calcium, magnesium, and vitamin D supplementations as complementary therapy for hypertensive patients: a systematic review and meta-analysis.钙、镁和维生素D补充剂作为高血压患者的辅助治疗:一项系统评价和荟萃分析。
BMC Complement Med Ther. 2025 Mar 5;25(1):89. doi: 10.1186/s12906-025-04809-x.
3
Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials.
有效开具口服镁治疗高血压处方:49 项临床试验的分类系统评价。
Nutrients. 2021 Jan 10;13(1):195. doi: 10.3390/nu13010195.
4
Challenges in the Diagnosis of Magnesium Status.镁状态诊断中的挑战。
Nutrients. 2018 Sep 1;10(9):1202. doi: 10.3390/nu10091202.
5
Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.观点:建立基于证据的血清镁参考区间的时机已到。
Adv Nutr. 2016 Nov 15;7(6):977-993. doi: 10.3945/an.116.012765. Print 2016 Nov.
6
Magnesium in disease.镁与疾病。
Clin Kidney J. 2012 Feb;5(Suppl 1):i25-i38. doi: 10.1093/ndtplus/sfr165.
7
Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats.补充镁与血管紧张素 II 受体阻滞剂对低镁血症大鼠的降压作用。
Korean J Intern Med. 2013 Mar;28(2):197-205. doi: 10.3904/kjim.2013.28.2.197. Epub 2013 Feb 27.
8
Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease?低镁血症是印度冠状动脉疾病患者的冠状动脉危险因素吗?
J Cardiovasc Dis Res. 2012 Oct;3(4):280-6. doi: 10.4103/0975-3583.102698.
9
Magnesium and vascular changes in hypertension.镁与高血压中的血管变化
Int J Hypertens. 2012;2012:754250. doi: 10.1155/2012/754250. Epub 2012 Feb 29.
10
Non-pharmacological aspects of blood pressure management: what are the data?血压管理的非药物方面:有哪些数据?
Kidney Int. 2011 May;79(10):1061-70. doi: 10.1038/ki.2011.46. Epub 2011 Mar 9.